EUVIMEDEUVIMED entdecken
Crossref

The urinary 6-sulfatoxymelatonin level in patients with central serous chorioretinopathy and its correlation with choroidal vasculature

Kun Xu, Yue Xu, Zhonghua Luo, Qinmeng Shu, Lingyi Li, Jicheng Lin, Fengmei Yang, Ching-Kit Tsui, Xiaoyu Tang, Peiqi Wu, Haolin Kong, Shanshan Yu und 1 weitere

International Ophthalmology · 2025

DOI: 10.1007/s10792-025-03838-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Ophthalmology, 2025. Verfasst von Kun Xu und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and …. Hauptthemen laut MEDLINE: Central Serous Chorioretinopathy, Choroid, Melatonin. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Research Grant from Guangzhou Municipal Science and Technology Bureau in China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To investigate the changes in melatonin secretion levels and its association with choroidal vasculature parameters in patients with central serous chorioretinopathy (CSC). METHODS: In this study, 30 male patients were enrolled diagnosed with CSC and 30 healthy male controls. The choroidal vasculature system of all participants were assessed using ultra-widefield swept-source optical coherence tomography angiography (UWF-SS-OCTA). Specifically, we measured choroidal vascular volume (CVV), choroidal vascularity index (CVI), and choroidal thickness (CT). Additionally, the levels of urinary 6-sulfatoxymelatonin(6-SMT) in participants were determined using enzyme-linked immunosorbent assay. Finally, the correlations between normalized 6-SMT and choroidal vascular parameters were evaluated in CSC and controls. RESULTS: The levels of urinary normalized 6-SMT in CSC patients (24.8, 20.2 - 28.1) were significantly lower than the control group (36.1, 30.0 - 45.2, P < 0.001). Compared with the control group, CSC patients exhibited significantly larger average CVV, CVI, and CT (CVV: 44.6 ± 8.9 mm3 vs 38.2 ± 9.4 mm3, P < 0.01; CVI: 34.7% ± 1.8% vs 33.3% ± 3.0%, P = 0.03; CT: 242.2 ± 48.0 μm vs 207.2 ± 48.3 μm, P = 0.01). In all regions, negative correlations were found between normalized 6-SMT and CVV (maximum r-value was - 0.60, P < 0.0001), CVI (maximum r-value was - 0.57, P < 0.0001), and CT (maximum r-value was - 0.59, P < 0.0001) in all CSC and controls. Linear regression analysis showed that normalized 6-SMT was the only predictor of CVV, CVI, and CT (P < 0.05) in CSC patients. CONCLUSION: This study found that CSC patients had lower levels of urinary 6-SMT. The concentration of 6-SMT was associated with choroidal vasculature parameters. The decrease in melatonin secretion might be a risk factor for CSC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Serous ChorioretinopathyChoroidMelatoninHumansMaleTomography, Optical CoherenceFluorescein AngiographyAdultMiddle AgedBiomarkersFundus OculiEnzyme-Linked Immunosorbent Assay

Stichwörter der Autor:innen

Central serous chorioretinopathyChoroidal vasculatureMelatoninOptical coherence tomography angiography

Substanzen

6-sulfatoxymelatoninMelatoninBiomarkers

Autor:innen und Institutionen

  • State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocul…
  • Eye Institute, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai, Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Key Laboratory of My…

Förderung

  • Guangdong Basic and Applied Basic Research Foundation
  • Research Grant from Guangzhou Municipal Science and Technology Bureau in China

Zitieren

APA

Xu, K., Xu, Y., Luo, Z., Shu, Q., Li, L., Lin, J., Yang, F., Tsui, C. K., Tang, X., Wu, P., Kong, H., Yu, S., & Liang, X. (2025). The urinary 6-sulfatoxymelatonin level in patients with central serous chorioretinopathy and its correlation with choroidal vasculature. International Ophthalmology. https://doi.org/10.1007/s10792-025-03838-2

Vancouver

Xu K, Xu Y, Luo Z, Shu Q, Li L, Lin J, et al. The urinary 6-sulfatoxymelatonin level in patients with central serous chorioretinopathy and its correlation with choroidal vasculature. International Ophthalmology. 2025. doi:10.1007/s10792-025-03838-2

BibTeX
@article{Xu2025,
  author = {Xu, Kun and Xu, Yue and Luo, Zhonghua and Shu, Qinmeng and Li, Lingyi and Lin, Jicheng and Yang, Fengmei and Tsui, Ching-Kit and Tang, Xiaoyu and Wu, Peiqi and Kong, Haolin and Yu, Shanshan and Liang, Xiaoling},
  title = {The urinary 6-sulfatoxymelatonin level in patients with central serous chorioretinopathy and its correlation with choroidal vasculature},
  journal = {International Ophthalmology},
  year = {2025},
  doi = {10.1007/s10792-025-03838-2}
}
Kostenlos starten →